From: SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
(A) | (B) | (C) | (D) | (A) | (B) | (C) | (D) | (A) | (B) | (C) | (D) | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Categorical regression | SFRP1 | â—‹ | â—‹ | â—‹ | â—‹ | LAMC2 | â—‹ | â—‹ | â—‹ | â—‹ | ||||
SALL4 | â—‹ | â—‹ | â—‹ | â—‹ | SLC16A12 | HMGA1 | â—‹ | â—‹ | â—‹ | â—‹ | ||||
TACSTD1* | â—‹ | â—‹ | â—‹ | â—‹ | HOXA5 | â—‹ | â—‹ | â—‹ | â—‹ | LAD1 | â—‹ | â—‹ | ||
ANGPT1 | â—‹ | â—‹ | â—‹ | KIF1A | â—‹ | â—‹ | â—‹ | PFKFB3 | â—‹ | â—‹ | â—‹ | |||
TACSTD2* | â—‹ | â—‹ | â—‹ | â—‹ | H2AFY | â—‹ | â—‹ | â—‹ | DEFB1 | â—‹ | â—‹ | |||
IGSF21 | ATP5G2 | SRGN | â—‹ | â—‹ | â—‹ | |||||||||
EFNB1 | â—‹ | â—‹ | â—‹ | TM4SF1 | â—‹ | â—‹ | â—‹ | â—‹ | UCHL1 | â—‹ | â—‹ | â—‹ | â—‹ | |
MEST | â—‹ | â—‹ | â—‹ | â—‹ | GPR56* | â—‹ | â—‹ | â—‹ | â—‹ | ALDH3A1 | â—‹ | â—‹ | â—‹ | â—‹ |
SCG3 | â—‹ | S100P | â—‹ | â—‹ | â—‹ | â—‹ | EPB41L3 | â—‹ | â—‹ | â—‹ | ||||
PCA based unsupervised FE (PC4) | PCA based unsupervised FE (PC4) | RTN1 | â—‹ | â—‹ | â—‹ | |||||||||
F2R | â—‹ | â—‹ | â—‹ | â—‹ | SPINT2 | â—‹ | â—‹ | â—‹ | â—‹ | LAMA1 | â—‹ | â—‹ | â—‹ | |
DKK3 | â—‹ | â—‹ | â—‹ | â—‹ | CDH1 | â—‹ | â—‹ | â—‹ | â—‹ |